Manifestations of adverse events post Sinovac vaccine immunization at Wirasakti Hospital, Kupang
Accepted: 3 August 2022
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Background. Since it was first discovered, COVID-19 has spread worldwide and has been declared a pandemic by the World Health Organization. One of the various efforts made to prevent the spread of COVID-19 is the development of the COVID-19 vaccine. One of the vaccines developed and used by the Indonesian government is the Sinovac vaccine. However, like vaccines in general, there are always vaccine safety problems which are better known as adverse events following immunization (AEFI).
Objective. The purpose of this study is to determine the AEFI manifestations that occurred in Sinovac vaccination participants at Wirasakti Hospital, Kupang.
Methods. The sample included 51 people, who later became known as research subjects. The criteria for vaccine recipients and instructions for recording AEFI refer to the technical guidelines issued by the Ministry of Health, namely the Decree of the Director General of Disease Prevention and Control number HK.02.02/4/1/2021 regarding technical instructions for implementation of vaccination in the context of combating pandemic COVID-19.
Results. The results showed that out of 198 vaccination participants, 15 of them had AEFI and those who had AEFI were women. The AEFI manifestations that occur are dizziness, palpitations, shortness of breath, cramps in the hands, and trembling hands. All AEFI that occurred are non-serious in nature.
Conclusion. Sinovac vaccine is relatively safe to use because only a small proportion of respondents (29.4%) have AEFI.
Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun J. 2020;109(102433):1–4. DOI: https://doi.org/10.1016/j.jaut.2020.102433
Ren L-L, Wang Y-M, Wu Z-Q, Xiang Z-C, Guo L, Xu T, et al. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl). 2020;133(9):1015–24. DOI: https://doi.org/10.1097/CM9.0000000000000722
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan , China. Lancet. 2020;395(February 15):497–506. DOI: https://doi.org/10.1016/S0140-6736(20)30183-5
WHO. Naming the coronavirus disease (COVID-19) and the virus that causes it. 2020.
Kochhar S, Salmon DA. Planning for COVID-19 vaccines safety surveillance. Vaccine. 2020;38(July):6194–8. DOI: https://doi.org/10.1016/j.vaccine.2020.07.013
Worldometer. Covid live update. 2021.
Satgas Covid-19. Peta sebaran covid-19. 2021. DOI: https://doi.org/10.35580/lageografia.v19i3.18670
Prüβ BM. Current state of the first covid-19 vaccines. Vaccines. 2021;9(1):1–12. DOI: https://doi.org/10.3390/vaccines9010030
Koesnoe S. Teknis Pelaksanaan Vaksin Covid dan Antisipasi KIPI. SatGas Imunisasi Dewasa PB PAPDI PP Perhimpun Alergi Imunol Jakarta Perhimpun Dr Spes Penyakit Dalam Indones cab Bogor. 2021;
Jeon M, Oh CE, Lee J. Adverse Events Following Immunization Associated with Coronavirus Disease 2019 Vaccination Reported in the Mobile Vaccine Adverse Events Reporting System. 2021;36(March):1–8. DOI: https://doi.org/10.3346/jkms.2021.36.e114
Sastroasmoro S, Ismael S. Dasar-Dasar Metodologi Penelitian Klinis. III. Jakarta: CV. Agung Seto; 2008.
Centre for Infectious Disease Epidemiology and Research-NUS. COVID-19 Situation Report 419. Singapore; 2021.
Klein SL, Jedlicka A, Pekosz A. The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis. 2010;10(5):338–49. DOI: https://doi.org/10.1016/S1473-3099(10)70049-9
Harris T, Nair J, Fediurek J, Deeks SL. Assessment of sex-specific differences in adverse events following immunization reporting in Ontario, 2012–15. Vaccine. 2017;35(19):2600–4. DOI: https://doi.org/10.1016/j.vaccine.2017.03.035
Cook IF. Sex differences in injection site reactions with human vaccines. 2016;(January).
Poland GA, Ovsyannikova IG, Jacobson RM. Adversomics: The emerging field of vaccine adverse event immunogenetics. Pediatr Infect Dis J. 2009;28(5):431–2. DOI: https://doi.org/10.1097/INF.0b013e3181a6a511
Cook IF. Sex differences in injection site reactions with human vaccines. Hum Vaccin. 2009;5(7):441–9. DOI: https://doi.org/10.4161/hv.8476
Cate T, Couch R, Parker D, Baxter B. Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines - 1978. Rev Infect Dis. 1983;5:737–47. DOI: https://doi.org/10.1093/clinids/5.4.737
Klein SL, Pekosz A. Sex-based biology and the rational design of influenza vaccination strategies. J Infect Dis. 2014;209(SUPPL. 3). DOI: https://doi.org/10.1093/infdis/jiu066
Engler R, Nelson M, Klote M, Al E. Half- vs full-dose trivalent in- activated influenza vaccine (2004–2005): age, dose, and sex effects on immune responses. . Arch Intern Med. 2008;168:2405–14. DOI: https://doi.org/10.1001/archinternmed.2008.513
Pinheiro I, Dejager L, Libert C. X-chromosome-located microRNAs in immunity: might they explain male/female differences? The X chromo- some-genomic context may affect X-located miRNAs and downstream signaling, thereby contributing to the enhanced immune response of females. BioEssays. 2011;(33):791–802. DOI: https://doi.org/10.1002/bies.201100047
Stamova B, Tian Y, Jickling G, Al E. The X-chromosome has a different pattern of gene expression in women compared with men with ischemic stroke. Stroke. 2012;43:326–34. DOI: https://doi.org/10.1161/STROKEAHA.111.629337
Gordeeva L, Shabaldin A, Semenova E, Glushkov A. Influence of genetic and phenotypical factors on the efficiency of the vaccination of young children against diphtheria and measles. Zh Mikrobiol Epidemiol Immunobiol. 2006;2:42–6.
Whitacre CC. Sex differences in autoimmune disease. Nat Immunol. 2001;2(9):777–80. DOI: https://doi.org/10.1038/ni0901-777
Chang W-H. A review of vaccine effects on women in light of the COVID-19 pandemic. Taiwan J Obstet Gynecol. 2020;59(January):812–20. DOI: https://doi.org/10.1016/j.tjog.2020.09.006
Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev | Immunol. 2016;16:626–38. DOI: https://doi.org/10.1038/nri.2016.90
Fink AL, Klein SL. The evolution of greater humoral immunity in females than males : implications for vaccine efficacy. Curr Opin Psychol. 2018;6(Mach 29):16–20. DOI: https://doi.org/10.1016/j.cophys.2018.03.010
Fischinger S, Boudreau CM, Butler AL, Streeck H, Alter G. Sex differences in vaccine-induced humoral immunity. Semin Immunopathol. 2019;41(December 13):239–49. DOI: https://doi.org/10.1007/s00281-018-0726-5
Klein SL, Marriot I, Fish EN. Sex-based differences in immune function and responses to vaccination. Trans R Soc Trop Med Hyg hypersensitivity. 2015;109:9–15. DOI: https://doi.org/10.1093/trstmh/tru167
Ontario PH. Weekly Summary Adverse Events Following Immunization ( AEFIs ) for COVID-19 in Ontario : December 13 , 2020 to March 6 , AEFI Report Characteristics. 2021;1–14.
McCartney PR. Sex-Based Vaccine Response in the Context of COVID-19. JOGNN - J Obstet Gynecol Neonatal Nurs. 2020;49(5):405–8. DOI: https://doi.org/10.1016/j.jogn.2020.08.001
Copyright (c) 2023 the Authors
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.